Our study identified and validated a 6-SLC gene (SLC39A8, SLC2A3, SLC39A13, SLC35B1, SLC4A3, SLC12A2) signature that could predict prognosis of CRC patients. Here, SLC39A8 is linked to colorectal carcinoma.